General Information of the Compound
Compound ID |
CP0845531
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
NAFAZATROM
Show/Hide
|
||||||||||||||||||
Synonyms |
2,4-Dihydro-5-methyl-2-(2-(2-naphthalenyloxy)ethyl)-3H-pyrazol-3-one
3-Methyl-1-(2-(2-naphthyloxy)ethyl)-2-pyrazolin-5-one
3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-(2-(2-naphthalenyloxy)ethyl)-
5-methyl-2-(2-naphthalen-2-yloxyethyl)-4H-pyrazol-3-one
59040-30-1
AC1L28U1
BAY g 6575
BRN 0665222
Bay-g 6575
Bay-g-6575
DTXSID00207794
EINECS 261-571-1
K94216221B
NAFAZATROM
Nafazatrom [BAN:INN]
Nafazatrom [INN:BAN]
Nafazatromum
Nafazatromum [INN-Latin]
Oprea1_097893
SCHEMBL93681
UNII-K94216221B
ZINC1764
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C16H16N2O2
|
||||||||||||||||||
Molecular Weight |
268.316
|
||||||||||||||||||
Canonical SMILES |
CC1=NN(CCOc2ccc3ccccc3c2)C(=O)C1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C16H16N2O2/c1-12-10-16(19)18(17-12)8-9-20-15-7-6-13-4-2-3-5-14(13)11-15/h2-7,11H,8-10H2,1H3
Show/Hide
|
||||||||||||||||||
InChIKey |
ISBUYSPRIJRBKX-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
59040-30-1
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound